SBP target of lower than 120 mmHg reduces risk of CV events in T2DM
The BPROAD study investigated whether intensive SBP reduction (<120 mmHg) vs. standard SBP reduction (<140 mmHg) offers greater protection for CV outcomes in patients with T2DM. Discussant Shawna Nesbitt reviews the results.
Media formats available:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Recommended
Sanjiv Shah, MD
Javed Butler, MD
Sanjit Jolly, MD
Stephen Nicholls, FRACP, FACC, FESC, FAHA
